Has Lezlie Malson received payments from drug or device companies?

Yes. Drug and device makers reported $9,032 in general payments to Lezlie Malson across 571 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lezlie Malson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lezlie Malson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lezlie Malson

Family · Jackson, MINPI 1073968657

Payments from drug & device makers

$9,032in general payments, 2019–2025

Across 571 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$2K
Amgen$891
AbbVie$804
Pfizer$632
Lilly USA, LLC$599
GSK$430
plus $4K from 38 others

What the payments were for

Food & beverage$8,97099%
Other$621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	89	$1,547
Amgen	59	$891
AbbVie	52	$804
Pfizer	42	$632
Lilly USA, LLC	40	$599
GSK	27	$430
Boehringer Ingelheim	19	$355
Merck	20	$319
Johnson & Johnson	22	$272
E.r. Squibb & Sons, L.L.C.	29	$252
Teva Pharmaceuticals USA, Inc.	20	$251
AstraZeneca	16	$250
Bayer	15	$214
Amarin Pharma, Inc.	13	$192
Aimmune Therapeutics, Inc.	6	$190
Kowa Pharmaceuticals America, Inc.	13	$180
Dexcom, Inc.	5	$157
Axsome Therapeutics, Inc.	8	$154
Takeda Pharmaceuticals U.S.A., Inc.	9	$141
Jazz Pharmaceuticals Inc.	7	$111
Nestle Healthcare Nutrition Inc.	5	$108
Biohaven Pharmaceuticals, Inc.	7	$103
Exact Sciences	5	$93
Collegium Pharmaceutical, Inc.	6	$89
Eisai Inc.	4	$77
Biohaven Pharmaceutical Holding Company Ltd.	5	$67
Baxter Healthcare	1	$62
Almatica Pharma LLC	3	$50
Sumitomo Pharma America, Inc.	2	$47
Averitas Pharma Inc.	2	$45
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$44
Inspire Medical Systems, Inc.	2	$43
Novartis	2	$37
Corcept Therapeutics	2	$31
Abbott	2	$29
Hologic Sales And Service, LLC	1	$23
Corium, LLC	1	$23
Viatris Specialty LLC	1	$23
Lundbeck LLC	1	$20
Esperion Therapeutics, Inc.	1	$20
Sanofi Pasteur Inc.	1	$18
Seqirus USA Inc	1	$16
IBSA Pharma Inc.	1	$13
Sanofi-aventis U.S. LLC	1	$11

How this compares

$9,032 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	12	$10,479
Levothyroxine Sodium	26	$739
Omeprazole	34	$364
Atorvastatin Calcium	36	$284
Tamsulosin Hcl	13	$280
Pravastatin Sodium	16	$258
Lisinopril	35	$231
Metoprolol Succinate	14	$219
Metformin Hcl	18	$149
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	12	$143
Simvastatin	19	$137
Amlodipine Besylate	24	$134
Methylprednisolone	29	$133
Tramadol Hcl	12	$46
Azithromycin	11	$39

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$632	$10,47912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.

Other family in Jackson

Jayme HeimGrandville$663K
Susan WolgamottBloomfield Township$327K
Elisheva EllenbergDetroit$150K
Sarah JohnsonFarmington Hills$119K
Daniela MaximTroy$112K
Kelsey PrinceGrand Rapids$87K
Brent MillerFremont$66K
Rachael CompeauFlint$62K
David KocendaLapeer$49K
Tracy RobertsonBay City$47K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →